IVI RMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field. The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer and became a leader in fertility treatment in Europe and Latin America. Its success rates have been one of the best in the sector since its inception, thanks to its continuous efforts in the teaching and research fields, which have put this company on the international vanguard of fertility care. RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States. Its success rates were consistently higher than the national average, thanks to cutting-edge research and state-of-the-art technology, and the group was soon recognized as a leader in the Americas. IVI and RMA merged in 2017, a turning point that transformed the assisted reproduction industry, creating the only global company in Europe, the United States and Latin America. The company finished 2020 with 65 clinics and more than 56,000 assisted reproduction treatments. IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients. • +190 Clinical Offices & +95 Labs in 15 Countries • +465 Physicians & Embryologists • +4,400 Employees • +100 babies born daily thanks to IVI RMA Global 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 & 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: • +3,000 Publications • 150 Researchers • 7 Researcher centers